We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

Two FTSE 100 dividend stocks I’d buy NOW

Plenty of FTSE 100 companies are offering very generous dividend yields at the moment. Here’s a look at two dividend stocks Edward Sheldon would buy now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As we begin November, stock market volatility is elevated. It’s not hard to see why. Covid-19, the US election, Brexit… there’s a lot of uncertainty right now.

Personally, I think this uncertainty is creating some fantastic buying opportunities for long-term investors, particularly in the dividend stock area. At present, plenty of well-established FTSE 100 companies are offering very generous yields. Here’s a look at two such dividend stocks I’d buy now.

A FTSE 100 dividend stock with a 5% yield

One FTSE 100 dividend stock I believe looks attractive at the moment is BAE Systems (LSE: BA). Its share price has been hammered recently. A month ago, it was near 500p. In the last week however, it has dipped below 400p.

There are a few reasons BAE’s share price has tanked over the last month. One is that investors are concerned that a Joe Biden US election win could result in lower US defence spending. Another is that there’s concern that government spending on Covid-19 will reduce the funds available to defence departments.

Both concerns are valid. However, I see the share price pullback as excessive. While Biden may not be as keen on defence as Trump, he’s made it clear that, if elected, he’ll push for continued military modernisation, including efforts to upgrade technology, strengthen cybersecurity, and develop drones and other autonomous vehicles.

And I don’t think defence spending in other countries is going to fall off a cliff. Given the high level of geopolitical tension worldwide, governments can’t afford to completely ignore defence.

It’s worth pointing out that only a few months ago, BAE’s chairman bought a ton of shares in the company at around the 480p mark. This suggests he thought there was value at that price. Today, the shares are much cheaper.

BAE is forecast to pay about 23p per share in dividends for this year. At the current share price, that equates to a yield of about 5.2%. The FTSE 100 stock’s forward-looking P/E ratio is about 10. All things considered, I see a lot of value here.

A dividend yield that’s hard to ignore

Another FTSE 100 dividend stock I’d snap up now is pharmaceutical giant GlaxoSmithKline (LSE: GSK). Like BAE, it’s underperformed recently. Over the last three months, its share price has fallen by about 10%. I think this share price weakness has created a great buying opportunity for dividend investors.

Glaxo’s third-quarter results, issued on 28 October, weren’t brilliant. For the period, turnover was down 3% at constant exchange rates while adjusted earnings per share were up just 1%. However, I’m convinced the long-term story here remains attractive.

In the long run, the company should benefit from both the world’s ageing population and increased healthcare spending in emerging economies. Meanwhile, by splitting up its business into two separate companies, it should create value for shareholders.

GSK is forecast to pay out 80p per share to investors this year. At the current share price, that equates to a dividend yield of 5.7%. In today’s low-interest-rate environment, I think that’s hard to ignore. The stock’s forward-looking P/E ratio is a very undemanding 11.7. Putting this all together, I see this FTSE 100 dividend stock as a buy right now.

Edward Sheldon owns shares in BAE Systems and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Hydrogen testing at DLR Cologne
Investing Articles

Is £15 the next stop for the Rolls-Royce share price?

Where will the Rolls-Royce share price go from here? Is a £15 price target for the next 12 months totally…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

How much is £7,620 saved in a Cash ISA a decade ago worth today?

Cash ISA savers have received an average of 4% over the last decade, but Harvey Jones says the average Stocks…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

702 shares in this FTSE 100 stalwart earn a £100 a month second income

Unilever shares come with an unusually high dividend yield. Should investors looking for a second income grab the opportunity with…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

This surging FTSE 100 share just hit £201! Will it ever split its stock? 

This high-quality FTSE 100 stock is up by a staggering 4,050% in the past 10 years. Why hasn't it split…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Just over £13 after its Q1 results, here’s why HSBC shares still look a bargain-basement buy for me anywhere below £20.68

HSBC shares have surged, but fresh results hint the market may still be missing a major value opportunity that long…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

GSK’s share price is down 18% despite another set of strong results! Time for me to buy more for under £19 while I can?

GSK’s share price has fallen far below what its earnings strength implies, creating a huge price-valuation gap long-term investors won't…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

A 6.7% forecast yield and 53% under ‘fair value’! 1 FTSE income share to buy today?

This FTSE income share looks deeply undervalued despite its high payouts and cash flows, creating a rare opportunity that yield…

Read more »

Close-up of British bank notes
Investing Articles

Here’s how I’m targeting £11,363 in yearly second income from £20,000 in Aberdeen shares!

Aberdeen shares have delivered consistently high yields for years, which, when compounded, could turn a £20k investment into very high…

Read more »